Resources
… Monoclonal antibodies (mAbs) represent a large part of pharmaceuticals currently … ~25 kDa connected by disulphide bridges. The production of mAbs is a lengthy and complex process. It is, however, … would be of great benefit to quickly characterise mAbs. Typical modifications followed during the production …